Actualité - Découvrez les nouveautés !
Vous trouvez ici les dernières nouveautés concernant les événements, les développements de produits et les publications de l'entreprise.
![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/Teaser/2023/4_Eyed_Professor_420x280.jpg)
Podcast, Part 2: What is Geographic Atrophy? Making the Invisible, Visible
Host Chris Lievens, OD chats with retinal experts, Jessica Haynes, OD and Steven Ferrucci, OD about the importance of high-quality imaging.
En savoir plus![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/Teaser/2023/4_Eyed_Professor_420x280.jpg)
Podcast, Part 1: What is Geographic Atrophy? Making the Invisible, Visible
Host Chris Lievens, OD sits down with retinal experts, Jessica Haynes, OD and Steven Ferrucci, OD to discuss geographic atrophy. They cover its prevalence and development, the role of high-quality imaging (SPECTRALIS, Heidelberg), and the importance of the doctor-patient relationship.
En savoir plus![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2023/05/1_monitoring-of-ga.png)
The importance of multimodal imaging in the diagnosis of AMD and geographic atrophy
The U.S. Food and Drug Administration (FDA) has approved a drug for the treatment of geographic atrophy (GA) for the first time, one of the advanced forms of dry age-related macular degeneration (AMD). The approval is considered a breakthrough in ophthalmology and finally gives patients hope of positively impacting the course of the disease.
En savoir plus![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2023/02/20230216_eNews-Oculamed-Thumb-480x300.jpg)
Heidelberg Engineering startet mit neuem Vertriebspartner in der Türkei
Seit dem 1. Januar 2023 übernimmt unser neuer offizieller Partner, OCULAMED Medikal Elektronik Ltd. Sti., die Distribution unseres wachsenden Produktportfolios in der Türkei und wird weiterhin den hohen Standard an Service und Weiterbildung anbieten, den Heidelberg Engineering Kund:innen gewohnt sind.
En savoir plus![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2023/01/20230118_Web-News_OIS_Podcast_HE.jpg)
OIS Podcast Episode on Heidelberg Engineering: Setting the Standards in Imaging
Sophia Pathai, MD, PhD, host of the Ophthalmic Innovation Source podcast, caught up with our Head of Corporate Strategy and Managing Director of MSI, Kfir Azoulay, as well as Tosh Vadhia, Managing Director of Heidelberg Engineering UK, to talk about the trends and opportunities in ophthalmology, including OCT-based biomarkers and artificial intelligence.
En savoir plus![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2022/11/GMOPC_Teaser_Launch_Thumb.jpg)
Heidelberg Engineering announces website launch of consortium dedicated to improving glaucoma detection
Heidelberg Engineering, an industry partner of the Glaucoma / Myopia OCT Phenotyping Consortium (GMOPC), welcomes the unveiling of the consortium’s official website.
En savoir plus![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2022/06/20220414_healio_ocular_surgery_news_Thumb.jpg)
Benefits of OCT before Cataract Surgery
Dr. Farrell "Toby" Tyson overviews his pre-surgery cataract workup routine and discusses his preference of imaging with SPECTRALIS as part of his patient screening process.
En savoir plus![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2022/03/Diagnosing-and-Treating-Glaucoma_Thumb.jpg)
Diagnosing and Treating Glaucoma webinar with Swarup Swaminathan, MD
Learn how to optimize the use of SPECTRALIS in your glaucoma practice and how to identify masqueraders that often get mistakenly treated as glaucoma.
En savoir plus![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2022/03/Approaches-to-Reviewing-OCTA-Images-of-CNV-with-Dr-Karl-Csaky_Thumb.jpg)
Approaches to Reviewing OCTA Images of CNV with Dr. Karl Csaky Online Webinar
During the webinar, Dr. Csaky presented four case presentations showcasing the value of OCTA imaging in clinical practice.
En savoir plus![](https://media.heidelbergengineering.com/_thumbnails/480x0/uploads/News/2022/03/Optical-coherence-tomography-in-multiple-sclerosis_thumb.jpg)
Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study
In this peer-reviewed long term, prospective study of patients with intermittent multiple sclerosis published in the Annals of Clinical and Translational Neurology, SPECTRALIS OCT was used to image inner retinal layers with the authors noting, “OCT has potential to estimate rates of neurodegeneration in the retina and brain.”
En savoir plus